Statistical optimization of levan: Influence of the parameter on levan structure and angiotensin I-converting enzyme inhibitory

Int J Biol Macromol. 2020 May 1:158:945-952. doi: 10.1016/j.ijbiomac.2020.04.232. Online ahead of print.

Abstract

Based on Plackett-Burman design, steepest ascent method, and Box-Behnken design, statistical optimization for B. subtilis AF17 for levan production was carried out. Sucrose, tryptone and initial pH were found to be the most significant parameter (P < 0.05) for levan production. Result showed that the optimum condition was sucrose 162.5 g/L, tryptone 10 g/L, initial pH 7 and maximum yield was 7.9 ± 0.18 g/L in 72 h fermentation. Purified levan was characterized using various physicochemical techniques such as GC-MS, 1H NMR, 13C NMR spectroscopy and SEC/TDA. Based on this data, the structure of levan was independent of initial culture conditions. The biomedical potential of the isolated Bacillus subtilis A17 levan for its angiotensin-I converting enzyme (ACE) inhibition activities was exploited in vitro. Interestingly, levan possessed an important angiotensin I converting enzyme (ACE) inhibitory 81.1 ± 4.1% at 4 mg/mL. The overall, data suggested that levan presents a promising natural source of antihypertensive agents.

Keywords: Bacillus subtilis AF17; Biological activity; Levan; Optimization; Response surface methodology.